Related Experiment Videos
Chronic cyclosporine nephrotoxicity. A rodent model
D M Gillum1, L Truong, J Tasby
1Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
Transplantation
|August 1, 1988
Summary
Researchers developed a new rat model for chronic cyclosporine (CsA) nephrotoxicity, accurately mimicking human kidney damage. This model shows interstitial fibrosis, tubular atrophy, and JGA changes, advancing CsA toxicity research.
Area of Science:
- Nephrology
- Toxicology
- Animal Models
Background:
- Chronic cyclosporine (CsA) nephrotoxicity is a significant clinical issue.
- Existing rodent models fail to fully replicate human-specific CsA-induced kidney damage, hindering research.
- Key human pathological features like interstitial fibrosis and tubular atrophy are poorly represented in current models.
Purpose of the Study:
- To establish and validate a reproducible rodent model for chronic CsA nephrotoxicity.
- To develop a model that accurately reflects human pathological changes in the kidney.
- To facilitate further investigation into the mechanisms and treatment of CsA-induced kidney injury.
Main Methods:
- Male Sprague-Dawley rats were administered CsA (25 mg/kg/d i.p.) in olive oil for 28 days.
- Control animals received olive oil only and were pair-fed.
- Histopathological analysis, body weight, and glomerular filtration rate (GFR) were assessed.
Main Results:
- The CsA-treated group developed interstitial fibrosis, tubular atrophy, interstitial inflammation, and juxtaglomerular apparatus (JGA) hypertrophy/hyperplasia.
- CsA-treated rats exhibited significantly reduced weight gain and depressed GFR compared to controls.
- The model was well-tolerated, without peritonitis, and JGA changes were minimal in controls.
Conclusions:
- This CsA administration protocol in rats successfully reproduces key features of chronic human CsA nephrotoxicity.
- The developed model offers a valuable tool for studying CsA-induced kidney disease.
- Further research utilizing this model can advance understanding and therapeutic strategies for CsA nephrotoxicity.